In some patients, however—particularly those experiencing GI symptoms of PASC—populations of cytotoxic CD4+ and CD8+ T-cells continue to evolve into new clones, suggesting a role for T-cell-mediated inflammation in PASC (285). Here, CD4 is linked to long COVID-19.